Crestline Management’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-66,599
Closed -$369K 578
2024
Q4
$369K Buy
+66,599
New +$369K 0.01% 585